Studies have shown that SLC25A1 is an essential component of the tumor cell metabolism and have enlightened novel mechanisms and therapeutic perspectives for the treatment of resistant non-small cell lung cancer tumors [51]. This evidence concerns the gene SLC25A1 and neoplasm.